Navigation Links
Indevus Pharmaceuticals To Present at RBC Capital Markets Conference
Date:12/5/2007

mpany's filings under the Securities Act of 1933 and the Securities Exchange Act of 1934 under "Risk Factors" and elsewhere, and include, but are not limited to: dependence on the success of SANCTURA(R), SANCTURA(R) XR, NEBIDO(R) , VANTAS(R) and SUPPRELIN(R) LA; the early state of products under development; uncertainties relating to clinical trials, regulatory approval and commercialization of our products, particularly SANCTURA XR, NEBIDO, and VALSTAR(TM); risks associated with contractual agreements, particularly for the manufacture and co-promotion of SANCTURA and SANCTURA XR and the manufacture of NEBIDO, VANTAS, SUPPRELIN LA and VALSTAR; dependence on third parties for supplies, particularly for histrelin, manufacturing, marketing, and clinical trials; competition; need for additional funds and corporate partners, including for the development of our products; failure to acquire and develop additional product candidates; changes in reimbursement policies and/or rates for SANCTURA, VANTAS, SUPPRELIN LA, DELATESTRYL(R) and any future products; history of operating losses and expectation of future losses; product liability and insurance uncertainties; risks relating to the Redux- related litigation; the risk that the businesses of Indevus and Valera Pharmaceuticals, Inc. will not be integrated successfully during the period following the related merger; the risk that the cost savings and any other synergies from the merger may not be fully realized or may take longer to realize than expected; market acceptance for the merger and approved products; risks of regulatory review and clinical trials; disruption from the transaction making it more difficult to maintain relationships with customers, employees or suppliers; competition and its effect on pricing, spending, third-party relationships and revenues; reliance on intellectual property and having limited patents and proprietary rights; dependence on market exclusivity, valuation of our Common Stock; risks related
'/>"/>
SOURCE Indevus Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Indevus Pharmaceuticals to Present at Upcoming Investor Conferences
2. FDA Accepts New Drug Application for NEBIDO(R) Submitted by Indevus
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Transcept Pharmaceuticals, Inc. to Present at 2007 BIO Investor Forum
6. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
7. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
9. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
11. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... Mew and Company, a Vancouver corporate tax ... business consulting services in addition to a variety of ... succession planning. Company finances are a complicated matter that ... of this, complex Canadian tax laws can make it ... result, Mew and Company works to advise their clients ...
(Date:2/28/2015)... CA (PRWEB) February 28, 2015 A ... a promising new gene therapy procedure for the treatment ... blindness in patients. Authored by Dr. Robert ... and published in the Lancet Medical Journal on January ... from choroideremia, a rare genetic disorder that mostly affects ...
(Date:2/28/2015)... Portland, OR (PRWEB) February 28, 2015 ... at the 2015 Japan Architecture & Construction Materials Show, ... They’ll join more than 1,000 suppliers and top manufacturers ... , Reclaimed wood products sourced and manufactured ... facilities have found popularity in Japan at restaurants, hotels, ...
(Date:2/28/2015)... FL (PRWEB) February 28, 2015 ... organization has sponsored visitor health insurance programs for visitors ... years. Most Indian elderly parents traveling to the United ... such as diabetes and blood pressure. These diseases are ... not even list them as medical conditions. There were ...
(Date:2/28/2015)... Boardman, Ohio (PRWEB) February 28, 2015 ... Bold? Motivational? Supportive? Strategic? , There are all ... unique strengths. To raise awareness of the advantages ... analysis firm PeopleKeys is launching a new product ... help clients better understand the connection between personality ...
Breaking Medicine News(10 mins):Health News:Vancouver Corporate Tax Accountants Now Provide Business Consulting Services 2Health News:New Gene Therapy Procedure Could Hold Key to Preventing Blindness for Certain Patients 2Health News:US Reclaimed Wood from Pioneer Millworks to be Featured at Architecture & Construction Materials Show in Tokyo. 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3Health News:PeopleKeys Launches The Leadership Report 2Health News:PeopleKeys Launches The Leadership Report 3
... of smokers who dont show any signs of respiratory problems may ... lead to lung disease later in life. ,The study ... at University Medical Centre Utrecht in the Netherlands. ,As ... 12 without any history of lung or airway disease. ...
... that it can also tell you how to commit suicide. ... Gestier, were found hanging from a tree in a national park ... before their bodies were found. The apparent suicide pact had sent ... from an internet site, Rob Gater, father of Jodie Gater, said ...
... which has entered into generic licensing deals with 10 ... is hoping to get a patent in India ... implementing our access programme and licensed Indian pharmas to ... a day for the pill," Gregg Alton, senior vice ...
... Nations' Food and Agriculture Organisation (FAO) has warned against the ... "serious". The country needs a long term strategy to control ... no cases of human infection have been reported in Bangladesh, ... destroyed as the virus spread to 11 out of 64 ...
... from Singapore, the tropical city-state saw a ... in the first trimester of this year compared to the same ... January to May 12 rose to 1,488, an increase from 993 ... was quoted. ,Experts cite this figure as an all ...
... the Virginia Commonwealth University Medical Center say that peginterferon ... . ,Lead researcher Dr. Mitchell Shiffman says ... in combination with ribavirin, points to a cure for ... liver cancer and the need for liver transplant. ...
Cached Medicine News:Health News:Australian Girls Took Instructions to Commit Suicide from Internet Site 2Health News:Australian Girls Took Instructions to Commit Suicide from Internet Site 3Health News:Gilead's AIDS Drug Awaits Patent in India 2Health News:Bird Flu: Bangladesh Situation Serious, Indian on High Alert 2Health News:Figures of Dengue In Singapore On The Rise 2Health News:Researchers Claims to Have Found Cure for Hepatitis C 2
(Date:2/27/2015)... , Feb. 27, 2015  Uroplasty, Inc. (NASDAQ: ... manufactures and markets innovative proprietary products to treat voiding ... 27th Annual ROTH Conference on Tuesday, March 10, 2015. ... Brett Reynolds , Chief Financial Officer, will present at ... on one at the conference at the Ritz Carlton ...
(Date:2/26/2015)... 27, 2015 RnRMarketResearch.com adds ... research report to its store. This report p ... pipeline. The report "Corneal Ulcers - Pipeline Review, ... development for Corneal Ulcers. Corneal Ulcers are primarily ... infections, viral infections & fungal infections. The symptoms ...
(Date:2/26/2015)... Ind. , Feb. 26, 2015  Mobility Ventures ... an agreement with Bank of America (NYSE: ... nationwide to receive financing of the revolutionary MV-1 - ... designed from the ground up to provide safe and ... applicants can use their loan to purchase a new ...
Breaking Medicine Technology:Uroplasty to Participate in the 27th Annual ROTH Conference 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 2Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 3Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 4Corneal Ulcers Therapeutics Companies and Drugs Pipeline H2 2014 Review Research Report 5Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 2Mobility Ventures and Bank of America Announce New Agreement to Simplify Retail Consumer Financing for MV-1 Universally Accessible Vehicle 3
... Sermo ( http://www.sermo.com/client ), the ... free Sermo Report titled, " FDA Committee Recommends Approval ... the introduction of an investigational oral antiplatelet treatment for ... of physicians feel that ticagrelor will likely affect the ...
... Inc. (OTC Bulletin Board: AEMD ), the ... disease and cancer, announced today that the Medanta Independent ... has approved a treatment program entitled: "Use of the ... with Standard of Care (SOC) Drug Therapy."  The Medicity ...
Cached Medicine Technology:Sermo Report Indicates that Ticagrelor is Likely to Affect the Standard of Care for ACS Patients 2Aethlon Medical Announces Approval of Hepatitis C Virus (HCV) Treatment Program 2Aethlon Medical Announces Approval of Hepatitis C Virus (HCV) Treatment Program 3Aethlon Medical Announces Approval of Hepatitis C Virus (HCV) Treatment Program 4Aethlon Medical Announces Approval of Hepatitis C Virus (HCV) Treatment Program 5Aethlon Medical Announces Approval of Hepatitis C Virus (HCV) Treatment Program 6
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: